These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 17827927)

  • 21. Design and evaluation of floating multi-layer coated tablets based on gas formation.
    Sungthongjeen S; Sriamornsak P; Puttipipatkhachorn S
    Eur J Pharm Biopharm; 2008 May; 69(1):255-63. PubMed ID: 17967527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrix polymeric excipients: comparing a novel interpolyelectrolyte complex with hydroxypropylmethylcellulose.
    Lu Z; Chen W; Olivier E; Hamman JH
    Drug Deliv; 2008 Feb; 15(2):87-96. PubMed ID: 18293194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accelerating the dissolution of enteric coatings in the upper small intestine: evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release.
    Varum FJ; Merchant HA; Goyanes A; Assi P; Zboranová V; Basit AW
    Int J Pharm; 2014 Jul; 468(1-2):172-7. PubMed ID: 24727141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double-layered mucoadhesive tablets containing nystatin.
    Llabot JM; Manzo RH; Allemandi DA
    AAPS PharmSciTech; 2002; 3(3):E22. PubMed ID: 12916937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A formulation approach for development of HPMC-based sustained release tablets for tolterodine tartrate with a low release variation.
    Cao QR; Choi JS; Liu Y; Xu WJ; Yang M; Lee BJ; Cui JH
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1720-30. PubMed ID: 23062115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous probing of swelling, erosion and dissolution by NMR-microimaging--effect of solubility of additives on HPMC matrix tablets.
    Tajarobi F; Abrahmsén-Alami S; Carlsson AS; Larsson A
    Eur J Pharm Sci; 2009 May; 37(2):89-97. PubMed ID: 19429415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel asymmetric membrane osmotic pump capsule with in situ formed delivery orifices for controlled release of gliclazide solid dispersion system.
    Yang Y; Zhao Z; Wang Y; Yang L; Liu D; Yang X; Pan W
    Int J Pharm; 2016 Jun; 506(1-2):340-50. PubMed ID: 27132166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imperatorin sustained-release tablets: In vitro and pharmacokinetic studies.
    Pan J; Lu W; Li C; Wang S; He L
    Arch Pharm Res; 2010 Aug; 33(8):1209-16. PubMed ID: 20803124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Matrices containing NaCMC and HPMC 2. Swelling and release mechanism study.
    Conti S; Maggi L; Segale L; Ochoa Machiste E; Conte U; Grenier P; Vergnault G
    Int J Pharm; 2007 Mar; 333(1-2):143-51. PubMed ID: 17240091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation of the traditional Chinese medicine compound recipe Shuxiong sustained-release capsules by multiparticulate time-controlled explosion technology.
    Song HT; Zhang Q; Wang HJ; Guo XJ; Chen DW; He ZG
    Pharmazie; 2007 May; 62(5):372-7. PubMed ID: 17557747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Compression of coated drug beads for sustained release tablet of glipizide: formulation, and dissolution.
    Nguyen C; Christensen JM; Ayres JW
    Pharm Dev Technol; 2014 Feb; 19(1):10-20. PubMed ID: 23259589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modified release from hydroxypropyl methylcellulose compression-coated tablets.
    Rujivipat S; Bodmeier R
    Int J Pharm; 2010 Dec; 402(1-2):72-7. PubMed ID: 20883759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo evaluation of gliclazide push-pull osmotic pump coated with aqueous colloidal polymer dispersions.
    Tang X; Tai LY; Yang XG; Chen F; Xu HM; Pan WS
    Drug Dev Ind Pharm; 2013 Jan; 39(1):67-76. PubMed ID: 22339718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel design of osmotic chitosan capsules characterized by asymmetric membrane structure for in situ formation of delivery orifice.
    Wang GM; Chen CH; Ho HO; Wang SS; Sheu MT
    Int J Pharm; 2006 Aug; 319(1-2):71-81. PubMed ID: 16701971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of formulation parameters on the drug release and floating properties of gastric floating two-layer tablets with acetylsalicylic acid.
    Hasçiçek C; Yüksel-Tilkan G; Türkmen B; Ozdemir N
    Acta Pharm; 2011 Sep; 61(3):303-12. PubMed ID: 21945909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel system for three-pulse drug release based on "tablets in capsule" device.
    Li B; Zhu J; Zheng C; Gong W
    Int J Pharm; 2008 Mar; 352(1-2):159-64. PubMed ID: 18055142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors affecting the release of nifedipine from a swellable elementary osmotic pump.
    Nokhodchi A; Momin MN; Shokri J; Shahsavari M; Rashidi PA
    Drug Deliv; 2008 Jan; 15(1):43-8. PubMed ID: 18197523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Highly Soluble Drugs Directly Granulated by Water Dispersions of Insoluble Eudragit® Polymers as a Part of Hypromellose K100M Matrix Systems.
    Mašková E; Naiserová M; Kubová K; Mašek J; Pavloková S; Urbanová M; Brus J; Vysloužil J; Vetchý D
    Biomed Res Int; 2019; 2019():8043415. PubMed ID: 30949510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Study on prescription screening and preparation process of compound danshen pulse capsule].
    Li X; Wang XY; Wu WQ; Zhao JF; Li JM
    Zhongguo Zhong Yao Za Zhi; 2013 Dec; 38(24):4309-13. PubMed ID: 24791536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Controlled-release effervescent floating matrix tablets of ciprofloxacin hydrochloride: development, optimization and in vitro-in vivo evaluation in healthy human volunteers.
    Tadros MI
    Eur J Pharm Biopharm; 2010 Feb; 74(2):332-9. PubMed ID: 19932750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.